VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $2,130,000 | -21.5% | 11,946 | -2.3% | 0.35% | -13.5% |
Q2 2015 | $2,714,000 | -8.5% | 12,221 | -18.2% | 0.41% | -7.3% |
Q1 2015 | $2,965,000 | +35.6% | 14,931 | -2.3% | 0.44% | +31.5% |
Q4 2014 | $2,186,000 | +1.0% | 15,281 | -7.4% | 0.33% | -1.2% |
Q3 2014 | $2,164,000 | -3.7% | 16,501 | -7.4% | 0.34% | -5.3% |
Q2 2014 | $2,248,000 | -12.0% | 17,826 | -8.0% | 0.36% | -17.2% |
Q1 2014 | $2,555,000 | +15.6% | 19,385 | +2.9% | 0.43% | +12.0% |
Q4 2013 | $2,211,000 | +6.8% | 18,840 | -5.1% | 0.38% | -1.8% |
Q3 2013 | $2,070,000 | +21.9% | 19,850 | +0.6% | 0.39% | +13.0% |
Q2 2013 | $1,698,000 | – | 19,730 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |